THE TREATMENT OF REFRACTORY DEPRESSION USING PAROXETINE WITH LITHIUM AUGMENTATION

被引：5
|
作者：
CAMPRUBI, ME
PURI, BK
机构：
[1] Department of Psychiatry, Charing Cross Hospital, London, England
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 1995年 / 19卷 / 03期
关键词：
LITHIUM; MAJOR DEPRESSION; PAROXETINE; TREATMENT RESISTANCE;
D O I：
10.1016/0278-5846(95)00032-Q
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1. The case is described of a 68-year-old woman with DSM-III-R major depression who was treatment-resistant to paroxetine. 2. Low dose lithium addition, at a plasma level of 0.2 mM, led to a rapid and sustained remission of her illness.
引用
收藏
页码：515 / 517
页数：3
相关论文
共 50 条
  • [31] Pindolol augmentation of paroxetine and compliance in the treatment of depression: A cost-utility analysis
    Tome, M
    Isaac, M
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 388 - 388
  • [32] Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings
    Naomi M. Simon
    Kathryn M. Connor
    Richard T. LeBeau
    Elizabeth A. Hoge
    John J. Worthington
    Wei Zhang
    Jonathan R. T. Davidson
    Mark H. Pollack
    Psychopharmacology, 2008, 197 : 675 - 681
  • [33] Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings
    Simon, Naomi M.
    Connor, Kathryn M.
    LeBeau, Richard T.
    Hoge, Elizabeth A.
    Worthington, John J., III
    Zhang, Wei
    Davidson, Jonathan R. T.
    Pollack, Mark H.
    PSYCHOPHARMACOLOGY, 2008, 197 (04) : 675 - 681
  • [34] Tolerability of combined treatment with lithium and paroxetine in patients with bipolar disorder and depression
    Fagiolini, A
    Buysse, DJ
    Frank, E
    Houck, PR
    Luther, JF
    Kupfer, DJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (05) : 474 - 478
  • [35] Lithium or lamotrigine augmentation in treatment-resistant depression
    Rybakowski, J.
    Tuszewska, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S232 - S232
  • [36] Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine
    Landén, M
    Högberg, P
    Thase, ME
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (01) : 100 - 106
  • [37] Aripiprazole augmentation for treatment of patiens with major depression refractory to antidepressants
    Leotsakou, C.
    Sardis, A.
    Kalogeropoulou, A.
    Labiris, C.
    Kapsali, F.
    Papadopoulos, K.
    Pelka, P.
    Giovanoglou, M.
    Mantzari, E.
    Paterakis, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S265 - S265
  • [38] Triiodothyronine augmentation in the treatment of refractory depression - A meta-analysis
    Aronson, R
    Offman, HJ
    Joffe, RT
    Naylor, CD
    ARCHIVES OF GENERAL PSYCHIATRY, 1996, 53 (09) : 842 - 848
  • [39] Paroxetine augmentation with risperidone in therapy-resistant depression
    Knopf, U
    Hubrich-Ungureanu, P
    Thome, J
    PSYCHIATRISCHE PRAXIS, 2001, 28 (08) : 405 - 406
  • [40] EFFICACY OF LITHIUM-TRANYLCYPROMINE TREATMENT IN REFRACTORY DEPRESSION
    PRICE, LH
    CHARNEY, DS
    HENINGER, GR
    AMERICAN JOURNAL OF PSYCHIATRY, 1985, 142 (05): : 619 - 623
12345